Publications by authors named "Pascal van Elzakker"

Claim this Profile
T
T cell receptor-engineered T cells to treat solid tumors: T cell processing toward optimal T cell fitness.
Cor H J Lamers, Sabine van Steenbergen-Langeveld, Mandy van Brakel, Corrien M Groot-van Ruijven, Pascal M M L van Elzakker

Hum Gene Ther Methods· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term stability of T-cell activation and transduction components critical to the processing of clinical batches of gene-engineered T cells.
Cor H J Lamers, Pascal van Elzakker, Sabine C L van Steenbergen, Barbara A Luider, Corrien Groot

Cytotherapy· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of metastatic renal cell carcinoma with CAIX CAR-engineered T cells: clinical evaluation and management of on-target toxicity.
Cor Hj Lamers, Stefan Sleijfer, Sabine van Steenbergen, Pascal van Elzakker, Brigitte van Krimpen

Mol Ther· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune responses to transgene and retroviral vector in patients treated with ex vivo-engineered T cells.
Cor H J Lamers, Ralph Willemsen, Pascal van Elzakker, Sabine van Steenbergen-Langeveld, Marieke Broertjes

Blood· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gibbon ape leukemia virus poorly replicates in primary human T lymphocytes: implications for safety testing of primary human T lymphocytes transduced with GALV-pseudotyped vectors.
Cor H J Lamers, Ralph A Willemsen, Pascal M M L van Elzakker, Jan Willem Gratama, Reno Debets

J Immunother· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis